Luis H. Alejo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers”.

The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-19-1082

N/A

0DataRank · unranked

64 citations

Stacey E. P. Joosten, Svetlana E. Semina, Luis H. Alejo, Svitlana D. Brovkovych, Joshua D. Stender +8 more

Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines

Hormones and Cancer(2020)10.1007/s12672-020-00378-2

N/A

0DataRank · unranked

10 citations

Luis H. Alejo, Jonna Frasor, Emily Smart

Identification of a novel ER-NFĸB-driven stem-like cell population associated with relapse of ER+ breast tumors

Breast Cancer Research(2022)10.1186/s13058-022-01585-1

N/A

0DataRank · unranked

7 citations

Luis H. Alejo, Shivani Chopra, Nidhi S. Kansara, Irida Kastrati, Carol A. Sartorius +2 more

Estrogen Receptor-Regulated Gene Signatures in Invasive Breast Cancer Cells and Aggressive Breast Tumors

Cancers(2022)10.3390/cancers14122848

N/A

0DataRank · unranked

3 citations

Svetlana E. Semina, Luis H. Alejo, Nidhi S. Kansara, Jonna Frasor, Emily Smart